WITH AN EYE ON PATIENTS
Live / Registered — Registered (as of 10 Oct 2023)
What this means for you
Registered since 10 Oct 2023. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 10 Oct 2029: the §8 declaration of use).
Record
- Serial number
- 97272238
- Registration number
- 7186053
- Mark type
- Slogan / phrase
- Filed
- 17 Feb 2022
- Published for opposition
- 25 Jul 2023
- Registered
- 10 Oct 2023
- Next maintenance filing
- §8 declaration of use, due by 10 Oct 2029 (grace period to 10 Apr 2030)
- Attorney of record
- Kimberly Jarman
Goods and services
- Class 005 — Pharmaceuticals: Drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of ocular diseases and conditions, namely, uveitis and retinal disease
Owner
- EYEPOINT US, INC., WATERTOWN, MA, US
- EyePoint Pharmaceuticals US, Inc., Watertown, MA, US
- EyePoint Pharmaceuticals US, Inc., Watertown, MA, US
- EyePoint Pharmaceuticals US, Inc., Watertown, MA, US
Prosecution history
- 11 Mar 2026 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 10 Oct 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 10 Oct 2023 — REGISTERED-PRINCIPAL REGISTER
- 25 Jul 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Jul 2023 — PUBLISHED FOR OPPOSITION
- 05 Jul 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 Jun 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Jun 2023 — EXAMINER'S AMENDMENT ENTERED
- 16 Jun 2023 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 16 Jun 2023 — EXAMINERS AMENDMENT E-MAILED
- 16 Jun 2023 — EXAMINERS AMENDMENT -WRITTEN
- 02 Dec 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 02 Dec 2022 — NON-FINAL ACTION E-MAILED
- 02 Dec 2022 — NON-FINAL ACTION WRITTEN
- 01 Dec 2022 — ASSIGNED TO EXAMINER